{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:44:41Z","timestamp":1790066681461,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["DK057846"],"award-info":[{"award-number":["DK057846"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["AI66387"],"award-info":[{"award-number":["AI66387"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI109565"],"award-info":[{"award-number":["UM1AI109565"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006351","name":"Colton Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006351","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60276-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T14:06:17Z","timestamp":1748613977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes"],"prefix":"10.1038","volume":"16","author":[{"given":"Ana","family":"Lled\u00f3-Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Preston-Hurlburt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Higdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-5729","authenticated-orcid":false,"given":"Eddie","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0281-1240","authenticated-orcid":false,"given":"S. Alice","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4129-0254","authenticated-orcid":false,"given":"Elisavet","family":"Serti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-2642","authenticated-orcid":false,"given":"Tomokazu S.","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-6613","authenticated-orcid":false,"given":"Kevan C.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"60276_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold, K. C. et al. Type Diabetes TrialNet Study G. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N. Engl. J. Med. 381, 603\u2013613 (2019).","journal-title":"N. Engl. J. Med."},{"key":"60276_CR2","doi-asserted-by":"crossref","unstructured":"Sims, E. K. et al. Type Diabetes TrialNet Study G. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci. Transl. Med. 13, (2021).","DOI":"10.1126\/scitranslmed.abc8980"},{"key":"60276_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"60276_CR4","doi-asserted-by":"publisher","first-page":"e124714","DOI":"10.1172\/jci.insight.124714","volume":"3","author":"MP Pender","year":"2018","unstructured":"Pender, M. P. et al. Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI insight 3, e124714 (2018).","journal-title":"JCI insight"},{"key":"60276_CR5","doi-asserted-by":"publisher","first-page":"535738","DOI":"10.1155\/2013\/535738","volume":"2013","author":"AH Draborg","year":"2013","unstructured":"Draborg, A. H., Duus, K. & Houen, G. Epstein-barr virus in systemic autoimmune diseases. Clin. Dev. Immunol. 2013, 535738 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"60276_CR6","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fmicb.2017.01853","volume":"8","author":"LI Sakkas","year":"2017","unstructured":"Sakkas, L. I., Daoussis, D., Liossis, S.-N. & Bogdanos, D. P. The Infectious Basis of ACPA-Positive Rheumatoid Arthritis. Front Microbiol 8, 1853 (2017).","journal-title":"Front Microbiol"},{"key":"60276_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/BOR.0b013e3283535801","volume":"24","author":"JA James","year":"2012","unstructured":"James, J. A. & Robertson, J. M. Lupus and Epstein-Barr. Curr. Opin. Rheumatol. 24, 383\u2013388 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"60276_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"60276_CR9","doi-asserted-by":"crossref","unstructured":"Veroni, C. & Aloisi, F. The CD8 T cell-Epstein-Barr virus-B cell trialogue: A central issue in Multiple Sclerosis pathogenesis. Front. Immunol. 12, 665718 (2021).","DOI":"10.3389\/fimmu.2021.665718"},{"key":"60276_CR10","doi-asserted-by":"publisher","first-page":"007799","DOI":"10.1101\/cshperspect.a007799","volume":"2","author":"J-F Bach","year":"2012","unstructured":"Bach, J.-F. & Chatenoud, L. The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes. Cold Spring Harb. Perspect. Med. 2, 007799 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"60276_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMra020100","volume":"347","author":"J-F Bach","year":"2002","unstructured":"Bach, J.-F. The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases.  N. Engl. J. Med. 347, 911\u2013920 (2002).","journal-title":"N. Engl. J. Med."},{"key":"60276_CR12","doi-asserted-by":"publisher","first-page":"eaai7793","DOI":"10.1126\/sciimmunol.aai7793","volume":"1","author":"SA Long","year":"2016","unstructured":"Long, S. A. et al. Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes. Sci. Immunol. 1, eaai7793 (2016).","journal-title":"Sci. Immunol."},{"key":"60276_CR13","doi-asserted-by":"crossref","unstructured":"Perdigoto, A. L. et al. Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis. Diabetologia 62, 655\u2013664 (2019).","DOI":"10.1007\/s00125-018-4786-9"},{"key":"60276_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cellimm.2017.07.007","volume":"319","author":"SA Long","year":"2017","unstructured":"Long, S. A. et al. Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes. Cell Immunol. 319, 3\u20139 (2017).","journal-title":"Cell Immunol."},{"key":"60276_CR15","doi-asserted-by":"publisher","unstructured":"Lled\u00f3-Delgado A. et al. Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at-risk for type 1 diabetes. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci177492 (2024).","DOI":"10.1172\/jci177492"},{"key":"60276_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"60276_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","volume":"602","author":"SV Gearty","year":"2022","unstructured":"Gearty, S. V. et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature 602, 156\u2013161 (2022).","journal-title":"Nature"},{"key":"60276_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41590-020-0633-5","volume":"21","author":"HA Abdelsamed","year":"2020","unstructured":"Abdelsamed, H. A. et al. Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes. Nat. Immunol. 21, 578\u2013587 (2020).","journal-title":"Nat. Immunol."},{"key":"60276_CR19","doi-asserted-by":"crossref","unstructured":"Escobar G., Mangani D. & Anderson A. C. T cell factor 1: A master regulator of the T cell response in disease. Sci. Immunol. 5, 1\u201312 (2020).","DOI":"10.1126\/sciimmunol.abb9726"},{"key":"60276_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1182\/blood-2009-02-204875","volume":"115","author":"B Keymeulen","year":"2010","unstructured":"Keymeulen, B. et al. Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood 115, 1145\u20131155 (2010).","journal-title":"Blood"},{"key":"60276_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1126\/scitranslmed.3003401","volume":"4","author":"Waldron-Lynch F","year":"2012","unstructured":"Waldron-Lynch, F. et al. Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients. Sci. Transl. Med. 4, 118 (2012).","journal-title":"Sci. Transl. Med."},{"key":"60276_CR22","doi-asserted-by":"crossref","unstructured":"Xie Q. Y. et al. Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell-directed therapy for type 1 diabetes prevention. Sci. Transl. Med. 15 (2023).","DOI":"10.1126\/scitranslmed.adh0353"},{"key":"60276_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.190.4.567","volume":"190","author":"GJ Babcock","year":"1999","unstructured":"Babcock, G. J., Decker, L. L., Freeman, R. B. & Thorley-Lawson, D. A. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J. Exp. Med. 190, 567\u2013576 (1999).","journal-title":"J. Exp. Med."},{"key":"60276_CR24","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1128\/JVI.74.6.2612-2619.2000","volume":"74","author":"M Savard","year":"2000","unstructured":"Savard, M. et al. Infection of primary human monocytes by Epstein-Barr virus. J. Virol. 74, 2612\u20132619 (2000).","journal-title":"J. Virol."},{"key":"60276_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4049\/jimmunol.173.1.321","volume":"173","author":"S Salek-Ardakani","year":"2004","unstructured":"Salek-Ardakani, S., Lyons, S. A. & Arrand, J. R. Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alpha. J. Immunol. 173, 321\u2013331 (2004).","journal-title":"J. Immunol."},{"key":"60276_CR26","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1128\/JVI.00171-07","volume":"81","author":"S Tugizov","year":"2007","unstructured":"Tugizov, S. et al. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J. Virol. 81, 5484\u20135496 (2007).","journal-title":"J. Virol."},{"key":"60276_CR27","doi-asserted-by":"publisher","first-page":"1001145","DOI":"10.3389\/fimmu.2022.1001145","volume":"13","author":"ED SoRelle","year":"2022","unstructured":"SoRelle, E. D., Reinoso-Vizcaino, N. M., Horn, G. Q. & Luftig, M. A. Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro. Front. Immunol. 13, 1001145 (2022).","journal-title":"Front. Immunol."},{"key":"60276_CR28","doi-asserted-by":"publisher","first-page":"587380","DOI":"10.3389\/fimmu.2020.587380","volume":"11","author":"G Houen","year":"2021","unstructured":"Houen, G. & Trier, N. H. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front. Immunol. 11, 587380 (2021).","journal-title":"Front. Immunol."},{"key":"60276_CR29","doi-asserted-by":"publisher","first-page":"1028972","DOI":"10.3389\/fimmu.2022.1028972","volume":"13","author":"G Sch\u00f6nrich","year":"2022","unstructured":"Sch\u00f6nrich, G., Abdelaziz, M. O. & Raftery, M. J. Epstein-Barr virus, interleukin-10 and multiple sclerosis: A m\u00e9nage \u00e0 trois. Front Immunol. 13, 1028972 (2022).","journal-title":"Front Immunol."},{"key":"60276_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1172\/JCI16090","volume":"111","author":"KC Herold","year":"2003","unstructured":"Herold, K. C. et al. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala). J. Clin. Invest. 111, 409\u2013418 (2003).","journal-title":"J. Clin. Invest."},{"key":"60276_CR31","doi-asserted-by":"publisher","first-page":"34133","DOI":"10.1074\/jbc.M507831200","volume":"280","author":"RJ Ingham","year":"2005","unstructured":"Ingham, R. J. et al. The Epstein-Barr virus protein, latent membrane protein 2A, Co-opts tyrosine kinases used by the T cell receptor. J. Biol. Chem. 280, 34133\u201334142 (2005).","journal-title":"J. Biol. Chem."},{"key":"60276_CR32","doi-asserted-by":"publisher","first-page":"11583","DOI":"10.1073\/pnas.2034960100","volume":"100","author":"ME Ressing","year":"2003","unstructured":"Ressing, M. E. et al. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc. Natl. Acad. Sci. USA 100, 11583\u201311588 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60276_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76344-3","volume":"10","author":"B Mbiribindi","year":"2020","unstructured":"Mbiribindi, B. et al. Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function. Sci. Rep. 10, 19973 (2020).","journal-title":"Sci. Rep."},{"key":"60276_CR34","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/eji.201041258","volume":"41","author":"V Ablamunits","year":"2011","unstructured":"Ablamunits, V., Henegariu, O., Preston-Hurlburt, P. & Herold, K. C. NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody. Eur. J. Immunol. 41, 1832\u20131842 (2011).","journal-title":"Eur. J. Immunol."},{"key":"60276_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41423-023-01064-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Regulation of CD8+ T memory and exhaustion by the mTOR signals. Cell Mol. Immunol. 20, 1023\u20131039 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"60276_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nm0402-379","volume":"8","author":"V Appay","year":"2002","unstructured":"Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379\u2013385 (2002).","journal-title":"Nat. Med."},{"key":"60276_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/0961203319828530","volume":"28","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y. et al. Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis. Lupus 28, 445\u2013454 (2019).","journal-title":"Lupus"},{"key":"60276_CR38","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1101\/gr.264705.120","volume":"31","author":"T Hong","year":"2021","unstructured":"Hong, T. et al. Epstein-Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci. Genome Res. 31, 2185\u20132198 (2021).","journal-title":"Genome Res."},{"key":"60276_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley, J. B. et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat. Genet 50, 699\u2013707 (2018).","journal-title":"Nat. Genet"},{"key":"60276_CR40","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.2337\/db13-0345","volume":"62","author":"KC Herold","year":"2013","unstructured":"Herold, K. C. et al. Teplizumab (Anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes 62, 3766\u20133774 (2013).","journal-title":"Diabetes"},{"key":"60276_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"60276_CR42","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1093\/bioinformatics\/btaa1011","volume":"36","author":"DG Bunis","year":"2021","unstructured":"Bunis, D. G., Andrews, J., Fragiadakis, G. K., Burt, T. D. & Sirota, M. dittoSeq: universal user-friendly single-cell and bulk RNA sequencing visualization toolkit. Bioinformatics 36, 5535\u20135536 (2021).","journal-title":"Bioinformatics"},{"key":"60276_CR43","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"60276_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4049\/jimmunol.1700172","volume":"199","author":"K Cerosaletti","year":"2017","unstructured":"Cerosaletti, K. et al. Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes. J. Immunol. 199, 323\u2013335 (2017).","journal-title":"J. Immunol."},{"key":"60276_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"60276_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini, Y., Krieger, A. M. & Yekutieli, D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93, 491\u2013507 (2006).","journal-title":"Biometrika"},{"key":"60276_CR47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60276-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:03:48Z","timestamp":1750691028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60276-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60276"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60276-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the affiliation details for Hai Nguyen were incorrectly given as \u2018Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA\u2019 but should have been \u2018Center for Translational Immunology, Benaroya Research Institute at VirginiaMason, Seattle,WA, USA\u2019. The original article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.L. and K.C.H. are listed as a co-inventors for a patent on the use of teplizumab for delay of Type 1 diabetes. K.C.H. has consulted for Sanofi Pharma. The other authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5033"}}